Pasithea Therapeutics Corp. · NASDAQ:KTTA
Opaleye Management Inc. reported a 9.99% stake in Pasithea Therapeutics Corp. (Schedule 13G)
Event Apr 1, 2026 · Filed Apr 8, 2026
Opaleye Management Inc. reported a 9.99% stake in Pasithea Therapeutics Corp., 2,491,000 shares, as a passive investor on Apr 1, 2026. Filed Apr 8, 2026 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 2,491,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Opaleye Management Inc. | 9.99% | 2,491,000 |
| Opaleye, L.P. | 9.99% | 2,491,000 |
| James Silverman | 9.99% | 2,491,000 |
Source
Related
- Pasithea Therapeutics Corp.
- Opaleye Management Inc.
- Pasithea Therapeutics Corp. shareholders
- Schedule 13G/A · Opaleye Management Inc. · Jul 31, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G/A · Coastlands Capital LP · Jul 1, 2026
- Schedule 13G · Stonepine Capital Management, LLC · Jun 23, 2026
- Form 4 · Coastlands Capital LP · Jun 22, 2026
- Schedule 13G/A · Ameriprise Financial Inc · May 15, 2026